Free Trial

Pulse Biosciences Q3 2024 Earnings Report

Pulse Biosciences logo
$15.94 -0.15 (-0.93%)
As of 04:00 PM Eastern

Pulse Biosciences EPS Results

Actual EPS
-$0.21
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
-$0.19

Pulse Biosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pulse Biosciences Announcement Details

Quarter
Q3 2024
Time
After Market Closes
Remove Ads

Pulse Biosciences Earnings Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Comparing Beyond Air (NASDAQ:XAIR) & Pulse Biosciences (NASDAQ:PLSE)
See More Pulse Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pulse Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pulse Biosciences and other key companies, straight to your email.

About Pulse Biosciences

Pulse Biosciences (NASDAQ:PLSE) operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

View Pulse Biosciences Profile

More Earnings Resources from MarketBeat